Framing Analysis
A GFS Bern survey of 2,050 respondents conducted April-May found 62% support and 31% opposition for a new Swiss-EU agreement package. The poll was commissioned by Interpharma; parliament has discussed the deal since March after it was concluded following the 2024 U.S. election. Swiss voters separately rejected a Swiss People's Party proposal to cap population at 10 million.